Cover Image
市場調查報告書

附投藥管理功能注射器

Dose Management Injection Devices

出版商 Greystone Research Associates 商品編碼 320239
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
附投藥管理功能注射器 Dose Management Injection Devices
出版日期: 2014年12月02日 內容資訊: 英文
簡介

本報告提供具投藥管理功能注射器的市場相關調查,市場背景,附投藥管理功能的著注射器的設計要素,功能的種類,使用藥物的組合,市場機會及法律規章等的市場影響因素分析,以及彙整主要的企業簡介。

摘要整理

市場機會

  • 藥物輸送市場動態
  • 朝向自我施打的趨勢
  • 人口組成的轉變
  • 「智慧型」設備的創新
  • 投藥監控系統
  • 治療需求的推進因素
  • 競爭環境

附投藥管理功能的注射器:設計要素

  • 人體工學和品牌
  • 預填充型 vs 拋棄式用品
  • 成本、可靠性

注射藥物管理:商用設備、組合產品

  • 投藥記憶體
    • 固定給藥
      • hGH
        • SurePal
    • 可變給藥
      • 胰島素
        • OptiSet
        • Symlin Pen
      • 促濾泡素
        • Gonal-f Pen
      • hGH
        • Genotropin Disposable
    • 給藥 + 自上次給藥的時間
      • 胰島素
        • NovoPen 5
        • NovoPen Echo
    • 給藥 + 時間標記
      • hGH
        • Easypod
      • 胰島素
        • HumaPen Memoir
        • Pendiq
    • 主要的藥筒濃縮劑
      • 胰島素
      • HematroPen3
  • 附語音訊息/語音導覽注射器
    • 自動注射器
  • 售後市場/附加元件設備
    • 胰島素(上次注射時間)
      • Insulcheck
      • Timesulin

市場要素

  • 法律規章上的課題
  • 服藥遵守、可用性
  • 醫療部門的經濟學

企業簡介

目錄
Product Code: DMJ269K

Greystone Research Associates is pleased to announce the publication of a new market study. Dose Management Injection Devices: Markets, Players, Strategies and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, participants and commercial opportunities for injection devices that incorporate dose management features to assist patients in self-managing their drug administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Device Evolution and the Evolving Landscape for Injectable Drugs

For self-administration, compliance with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. Autoinjectors are designed to address the patient compliance issue by making the delivery of injectable drugs less complicated and intimidating. Efforts to enhance compliance have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. For chronic conditions compliance has a direct effect on the patient's quality-of-life. Injectable devices with Dose management features address the natural desire of patients for simplicity, and encourage enhanced compliance and appropriate behavior. Dose management features that are increasingly being integrated into injection devices include dose memory, dose time stamping, selectable cartridge concentration, and audible prompts. Markets include OEM devices and aftermarket add-on dose reminders.

image1

What You Will Learn

  • Provides detailed analysis of injection devices that incorporate features designed to assist patient in self-managing injectable drug dosing
  • Analyzes therapeutic demand drivers and evaluates commercial dose management injection devices in key product segments
  • Analyzes design factors, material selection issues, technologies and market development issues
  • Assesses key market segments, market dynamics and market demographics
  • Provides market data and forecasts
  • Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Evaluates the impact of economic, technology, and regulatory factors

Table of Contents

Executive Summary

The Market Opportunity

  • Delivery Market Dynamics
  • The Trend toward Self-Administration
  • Shifting Demographics
  • Innovation in 'Intelligent' Devices
  • Medication Event Monitoring Systems
  • Therapeutic Demand Drivers
  • Competitive Landscape

Dose Management Injection Device Design Factors

  • Ergonomics and Branding
  • Prefillable vs Disposable Designs
  • Cost and Reliability

Injectable Dose Management - Commercial Devices & Combination Products

  • Dose Memory
    • Constant Dosing
      • hGH
        • SurePal
    • Variable Dosing
      • Insulin
        • OptiSet
        • Symlin Pen
      • Follitropin
        • Gonal-f Pen
      • hGH
        • Genotropin Disposable
    • Dose + Time since Last Dose
      • Insulin
        • NovoPen 5
        • NovoPen Echo
    • Dose + Time Stamp
      • hGH
        • Easypod
      • Insulin
        • HumaPen Memoir
        • Pendiq
    • Selectable Cartridge Concentration
      • Insulin
      • HematroPen3
  • Audible Prompts/Voice-guided Injection
    • Autoinjectors
  • Aftermarket/Add-on Devices
    • Insulin (Time of Last Injection)
      • Insulcheck
      • Timesulin

Market Factors

  • Regulatory Issues
  • Patient Compliance and Ease of Use
  • Healthcare Economics

Company Profiles

Back to Top